# Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy Adults

> **NCT02656160** · PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 13 (actual)

## Conditions studied

- Sleep Apnea, Obstructive

## Interventions

- **DRUG:** Placebo
- **DRUG:** Dalfampridine

## Key facts

- **NCT ID:** NCT02656160
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2016-05
- **Final completion:** 2016-07
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2017-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02656160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02656160, "Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy Adults". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02656160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*